About
Novartis is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies in the world and is a leader in the research, development, and production of innovative healthcare products. Novartis was formed in 1996 through the merger of Ciba-Geigy and Sandoz, two major pharmaceutical companies with long histories.
The company has a diverse portfolio of products and therapies in areas such as oncology, immunology, ophthalmology, and cardiovascular disease. Novartis is committed to improving patient health and access to healthcare through its research, development, and distribution of innovative and high-quality products.
Novartis Medical Devices
1 – AcrySof®
ACRYSOF® is a type of intraocular lens (IOL) that is used to replace the natural lens of the eye during cataract surgery. Developed by Alcon, a division of Novartis, ACRYSOF® is designed to provide clear vision at a range of distances, reducing the need for glasses or contact lenses.
ACRYSOF® IOLs are made from a patented material called hydrophobic acrylic, which resists the build-up of proteins and other substances that can cloud the lens over time. They are available in a range of powers and designs to suit the specific needs of individual patients.
During cataract surgery, the natural lens of the eye is removed and replaced with an artificial lens, such as ACRYSOF®. The IOL is inserted through a small incision in the eye and then positioned in the same place as the natural lens. Once in place, the lens provides clear vision, allowing the patient to see more clearly than before.
ACRYSOF® IOLs have been used in millions of cataract surgeries worldwide and are considered safe and effective. As with any medical device, there are some risks associated with their use, such as infection, bleeding, or problems with vision. Patients should discuss the risks and benefits of ACRYSOF® with their healthcare provider before undergoing cataract surgery.
Medical Device List
- AcrySof®
